UBS Group AG (UBS) — Deep Stock Analysis¶
Date: July 28, 2026 | Ticker: NYSE: UBS | Sector: Banks — Diversified (Switzerland) Price at analysis: $52.03 | Market Cap: $162.4B | 52-wk Range: $35.94 - $55.15
Executive Summary¶
UBS is in the middle of a transformational post-Credit-Suisse integration that is running ahead of schedule. The bank generated $7.8B net profit in FY2025 (+53% YoY), and Q1 2026 was a blowout: $3.0B net profit (+80% YoY) with 17% return on CET1 capital. The wealth management franchise commands $7T+ in invested assets and the investment bank is firing on all cylinders (record Global Markets, strong ECM). Cost synergies are at $11.5B against a $13.5B target.
The single biggest overhang is the Swiss Federal Council's proposed capital rule changes, which could require an incremental ~$20B in CET1 capital (UBS estimates ~$37B total impact). Parliament is debating softer terms, with implementation 2029 at the earliest. Once this uncertainty clears, the stock could re-rate significantly.
Verdict: HOLD with a lean toward ACCUMULATE on dips. The underlying business is strong and executing well, but the stock is near 52-week highs and the regulatory fog hasn't lifted. Best entry on pullbacks toward $45-48.
1. Company Overview¶
UBS Group AG is a Swiss multinational investment bank and financial services company. It is the world's largest wealth manager, with a strong presence in Switzerland, the Americas, and Asia-Pacific. Founded in 1862 and headquartered in Zurich, UBS acquired Credit Suisse in a government-brokered rescue in March 2023.
Business Segments¶
| Segment | TTM Revenue | % of Total | Description |
|---|---|---|---|
| Global Wealth Management | $26.6B | 52% | Wealth planning, investment management, estate planning for HNWI/UHNWI |
| Investment Bank | $13.2B | 26% | Global Markets (equities, FICC), Global Banking (M&A, ECM, DCM) |
| Personal & Corporate Banking | $9.5B | 19% | Retail banking, mortgages, SME lending in Switzerland |
| Asset Management | $3.2B | 6% | Fund management, institutional mandates, alternatives |
| Non-Core & Legacy | -$0.1B | — | Credit Suisse runoff portfolio (being wound down) |
| Group Items | -$1.2B | — | HQ costs, funding costs, hedging |
Employees: 103,177 | Invested Assets: $7T+ | Founded: 1862 (origins), acquired CS in 2023
2. Financial Performance¶
Annual Results (USD millions)¶
| Metric | FY2023 | FY2024 | FY2025 | TTM (Q1'26) |
|---|---|---|---|---|
| Revenue | $40,834 | $48,611 | $49,573 | $51,260 |
| Revenue Growth | +18.1% | +19.1% | +2.0% | +5.8% |
| Net Income | $27,366¹ | $5,085 | $7,767 | $9,115 |
| Net Income Growth | +269% | -81.4% | +52.7% | +81.5% |
| Diluted EPS | $8.30 | $1.52 | $2.36 | $2.79 |
| Profit Margin | 67.1% | 10.6% | 15.7% | 17.9% |
¹ FY2023 includes a massive one-time gain from the acquisition of Credit Suisse (negative goodwill).
Q1 2026 — Blowout Quarter¶
- Net profit: $3.0B (+80% YoY)
- Revenue: $14.2B (+13% YoY, +18% in core franchises)
- Underlying RoCET1: 17.0%
- Underlying PBT: $4.0B (+54% YoY)
- Cost/income ratio: 72.5% (70.2% underlying)
- EPS: $0.94
- CET1 capital ratio: 14.7% (well above ~14% guidance)
- CET1 leverage ratio: 4.4% (above >4.0% guidance)
Segment highlights (Q1'26 vs Q1'25): - GWM revenue +11% (managed net new assets $37.4B) - P&C revenue +2% in CHF (Swisscard gain) - IB revenue +27% (record Global Markets, strong ECM) - NCL revenues negative vs +$284M prior year (expected wind-down)
3. Balance Sheet & Capital¶
Key Metrics¶
| Metric | Q1 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Cash & Equivalents | $245.8B | $229.5B | $242.2B |
| Total Debt | $343.9B | $328.5B | $322.1B |
| CET1 Capital Ratio | 14.7% | ~14.5% | 14.3% |
| CET1 Leverage Ratio | 4.4% | ~4.3% | 4.7% |
| Total Loss-Absorbing Capacity | — | ~$185B | ~$185B |
| Book Value Per Share | $29.72 | — | ~$27 |
UBS has a fortress balance sheet. The CET1 ratio of 14.7% is comfortably above the ~14% target, giving optionality for capital return.
4. Credit Suisse Integration — The Core Thesis¶
The CS acquisition is the defining strategic event. Three years in, execution has been impressive:
| Milestone | Status |
|---|---|
| Cumulative gross cost savings | $11.5B vs $13.5B target (end 2026) |
| NCL capital freed up | $8B |
| NCL RWA reduction | ~66% (2/3 reduction) |
| NCL cost reduction | ~80% vs FY2022 baseline |
| Client migration | Substantially complete |
| Expected full integration | End of 2026 |
| Additional savings identified | $500M incremental gross cost savings |
The Non-Core & Legacy unit (runoff portfolio) is being wound down faster than expected, releasing capital back to the core business.
5. Valuation¶
Current vs Historical¶
| Metric | Current | 5-Yr Avg | Peer Avg |
|---|---|---|---|
| Trailing P/E | 17.8x | ~12x | 15-18x |
| Forward P/E | ~14x | ~11x | 13-16x |
| Price/Book | 1.74x | ~1.0x | 1.2-1.5x |
| P/Tangible Book | ~1.8x | ~1.1x | — |
| P/S (TTM) | 3.17x | ~2.0x | — |
| P/FCF (TTM) | 5.01x | — | — |
| PEG Ratio (5yr) | 0.95 | — | — |
Key observations: - The P/B rerating to near 10-year highs reflects the market pricing in a successful CS integration and a more stable, wealth-heavy earnings mix - At 14x forward earnings with 17% RoCET1, the PEG ratio is ~0.95 — slightly below 1.0, suggesting fair-to-slightly-undervalued on a growth-adjusted basis - Book value per share of ~$29.72 provides a floor; the stock trades at 1.74x book, which is still below where high-quality wealth managers typically trade (2-3x)
6. Dividend & Capital Return¶
| Metric | Value |
|---|---|
| Dividend Per Share (FY2025) | $1.10 (+22% YoY from $0.90) |
| Dividend Yield (forward) | ~2.1% |
| Payout Ratio | ~47% of FY2025 earnings |
| Ex-Dividend Date | April 22, 2026 (paid April 23) |
The dividend was increased 22% in FY2025. The CEO has signaled an aim for mid-teens percentage capital return in FY2026, including buybacks, subject to: - Maintaining CET1 ratio ~14% - Performance and outlook - Visibility on parliamentary deliberations on capital rules
If buybacks resume, that would be a significant catalyst.
7. Risks & Challenges¶
Primary: Swiss Capital Regulation¶
- Proposal: Swiss Federal Council wants banks to fully back foreign subsidiaries with parent CET1 capital
- Estimated impact: ~$20B incremental CET1 for UBS (authorities); UBS estimates ~$37B total with ~$3B annual capital cost
- Status: Before parliament; upper house seen as more favorable to UBS
- Timeline: Not enforced before 2029 at earliest
- Risk level: High. Could constrain buybacks and dividend growth for years if full version passes
Secondary Risks¶
| Risk | Description |
|---|---|
| Integration execution | Final stages of CS wind-down; any operational stumbles could rattle confidence |
| Valuation rerating done | P/B at 10-yr highs — much of the good news may be priced in |
| Economic cycle | IB revenues cyclical; recession would hit fees, potentially credit losses |
| Litigation | Some legacy CS legal matters remain unresolved |
| Rate sensitivity | Falling rates could pressure NII in P&C and GWM lending |
| Geopolitical | Swiss-US tax treaty, Russia/CIS exposure, China tensions |
8. Analyst Consensus¶
| Source | Rating | Price Target | Notes |
|---|---|---|---|
| Consensus (Public.com) | Strong Buy (100%) | $60.30 | +12% upside |
| StockAnalysis (3 analysts) | Buy | $52.20 | +0.3% upside |
| BofA Securities | Buy | $60.30 | Most bullish large bank |
| Citi | Neutral | CHF 41.60 (Swiss listing) | Recently raised target |
| SM Initiation | — | $36.00 | Bearish outlier |
Street consensus is positive but price targets vary widely. The average implies modest upside from current levels. The bullish case ($60+) depends heavily on: - Continued strong earnings momentum - Benign resolution of Swiss capital rules - Resumption of buybacks
9. Price Action & Momentum¶
| Period | Return | vs S&P 500 |
|---|---|---|
| 1 Month | +2.6% | — |
| 3 Month | +25.5% | +11.1% |
| 6 Month | +9.5% | +8.7% |
| 9 Month | +31.1% | +15.6% |
| 1 Year | +44.2% | +20.6% |
Technical posture: - Price vs 200-day SMA: +20.7% (extended) - 50-day SMA: $47.79 (price 9% above) - 10-day SMA: $50.76 (price 2.6% above) - Beta: 0.83 (less volatile than market)
The stock is in a clear uptrend but has run hard and is approaching overbought territory relative to moving averages.
10. Outlook & Verdict¶
Bull Case ($55-65)¶
- CS integration completes on schedule by end 2026
- Cost base permanently lower, RoCET1 sustains 15-18%
- Swiss capital rules come in softer than feared (parliament compromise)
- Buybacks resume in H2 2026, driving EPS growth
- Wealth management AUM continues compounding
- P/E re-rates to 16-17x forward earnings → $55-65
Base Case ($48-55)¶
- Integration completes, cost savings largely delivered
- Capital rules impose some incremental burden but manageable
- Buybacks limited but not zero
- RoCET1 settles at ~14-15%
- Stock trades around current multiples with gradual upside
Bear Case ($36-45)¶
- Full Swiss capital requirements enacted (~$37B impact)
- $3B annual capital cost weighs on returns
- Buybacks suspended, dividend growth stalls
- Economic downturn pressures IB revenue and credit
- P/E compresses toward historical ~12x
Verdict¶
| If you... | Recommendation |
|---|---|
| Already own (up 30-44%) | HOLD. The story is intact. Consider selling 20-30% if you want to de-risk ahead of the capital rule decision. Q2 earnings tomorrow could be a volatility event. |
| Are looking to buy | WAIT for a pullback to $45-48 (near the 50-day SMA). At $52, near the top of the 52-week range, the risk/reward is less attractive. |
| Want to accumulate | DCA in. Start a small position now, add on any regulatory-driven dips. The underlying business quality is high and the CS integration is the best catalyst the bank has had in a decade. |
Key upcoming catalysts: 1. Q2 2026 earnings — July 29, 2026 (EPS est: $0.91) 2. Swiss parliamentary debate on capital rules — ongoing through 2026 3. Full integration completion — by end of 2026 4. Buyback announcement — possible in H2 2026
Disclaimer: This is not financial advice. Do your own research before making investment decisions.